Effects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 5, 2006, Pages

  Palan, Prabhudas R ^a   Magneson, Amy T ^a   Castillo, Monique ^a   Dunne, James ^b   Mikhail, Magdy S ^a  

^a Departments of Obstetrics and Gynecology   (India)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antioxidant; Coenzyme Q10; Menstrual cycle; Oral contraceptive use

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; ETHINYLESTRADIOL PLUS NORGESTIMATE; GAMMA TOCOPHEROL; LYCOPENE; ORAL CONTRACEPTIVE AGENT; UBIDECARENONE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLICULAR PHASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID SOLUBILITY; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; ALPHA-TOCOPHEROL; ANTIOXIDANTS; CONTRACEPTIVES, ORAL; CROSS-SECTIONAL STUDIES; FEMALE; FOLLICULAR PHASE; HUMANS; LIPIDS; LUTEAL PHASE; MENSTRUAL CYCLE; PREMENOPAUSE; SOLUBILITY; UBIQUINONE;

EID: 33646081769     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.11.032     Document Type: Article

References (17)

1. Wilcox J.K., Ash S.L., and Catignani G.L. Antioxidants and prevention of chronic disease. Critic Rev Food Sci Nutr 44 (2004) 275-295
2. 10 and cardiovascular disease: a review. J Cardiovasc Nurs 316 (2002) 9-20
3. Azzi A., Gysin R., Kempna P., Ricciarelli R., Villacorta L., Visarius T., et al. The role of α-tocopherol in preventing disease: from epidemiology to molecular events. Mol Aspects Med 24 (2003) 325-336
4. Sugioka K., Shimosegawa Y., and Nakano M. Estrogen as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 210 (1987) 37-39
5. Forman M.R., Johnson E.J., Lanza E., Graubard B.I., Beecher G.R., and Muesing R.A. Effect of menstrual cycle phase on the concentrations of individual carotenoids in lipoproteins of premenopausal women: a controlled dietary study. Am J Clin Nutr 67 (1998) 81-87
6. Lanza E., Forman M.R., Johnson E.J., Muesing R.A., Graubard B.I., and Beecher G.R. α-Tocopherol concentrations in plasma but not in lipoproteins fluctuate during the menstrual cycle in healthy premenopausal women. J Nutr 128 (1998) 1150-1155
7. Reimer R.A., Debert C.T., House J.L., and Poulin M.J. Dietary and metabolic differences in pre- versus postmenopausal women taking or not taking hormone replacement therapy. Physiol Behav 84 (2005) 303-312
8. 10, α-tocopherol and γ-tocopherol in preeclampsia and normal pregnancy. Gynecol Obstet Invest 58 (2004) 8-13
9. Palan P.R., Mikhail M.S., and Romney S.L. Placental and serum levels of carotenoids in preeclampsia. Obstet Gynecol 98 (2001) 459-462
10. Kardinaal A.F., van't Veer P., Brants H.A., van den Berg H., van Schoonhoven J., and Hermus R.J. Relations between antioxidant vitamins in adipose tissue, plasma, and diet. Am J Epidemiol 141 (1995) 440-450
11. Aftergood L., Alexander A.R., and Alfin-Slater R.B. Effect of contraceptive on plasma lipoproteins, cholesterol and α-tocopherol levels in young women. Nutr Rep Int 11 (1975) 295-304
12. Yeung D.L., and Chan P.L. Effects of progestogen and a sequential type of oral contraceptive on plasma vitamin A, vitamin E, cholesterol and triglycerides. Am J Clin Nutr 28 (1975) 686-691
13. Webb J.L. Nutritional effects of oral contraceptive use: a review. J Reprod Med 25 (1980) 150-156
14. Jagadeesan V., and Prema K. Plasma tocopherol and lipid levels in pregnancy and oral contraceptive users. BJOG 87 (1980) 903-907
15. Egan K.M., Lawson J.A., Fries S., Koller B., Rader D.J., Smyth E.M., et al. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306 (2004) 1954-1957
16. Fitzgerald G.A. COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nat Rev Drug Disc 2 (2003) 879-890
17. Molavi B., and Mehta J.L. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol 19 (2004) 488-493